Peer review reports
From: A four-year assessment of the characteristics of Rwandan FDA drug recalls
| Original Submission | ||
|---|---|---|
| 11 Sep 2023 | Submitted | Original manuscript |
| 27 Oct 2023 | Reviewed | Reviewer Report - Eliangiringa Kaale |
| 6 Dec 2023 | Reviewed | Reviewer Report - Jude Nwokike |
| 8 Dec 2023 | Reviewed | Reviewer Report - Albert Figueras |
| 1 Jan 2024 | Author responded | Author comments - Bahizi Marcel |
| 2 Jan 2024 | Author responded | Author comments - Bahizi Marcel |
| Resubmission - Version 2 | ||
| 1 Jan 2024 | Submitted | Manuscript version 2 |
| 3 Jan 2024 | Author responded | Author comments - Bahizi Marcel |
| Resubmission - Version 3 | ||
| 3 Jan 2024 | Submitted | Manuscript version 3 |
| 17 Jan 2024 | Reviewed | Reviewer Report - Albert Figueras |
| 22 Jan 2024 | Reviewed | Reviewer Report - Jude Nwokike |
| 25 Jan 2024 | Reviewed | Reviewer Report - Eliangiringa Kaale |
| 2 Apr 2024 | Author responded | Author comments - Bahizi Marcel |
| Resubmission - Version 4 | ||
| 2 Apr 2024 | Submitted | Manuscript version 4 |
| 4 Apr 2024 | Author responded | Author comments - Bahizi Marcel |
| Resubmission - Version 5 | ||
| 4 Apr 2024 | Submitted | Manuscript version 5 |
| Publishing | ||
| 24 Jun 2024 | Editorially accepted | |
| 4 Jul 2024 | Article published | 10.1186/s12889-024-19245-8 |